Cameron Snell

11PUBLICATIONS
85CO-AUTHORS
Predictive and prognostic markersTumour immunologyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 27, 2025
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2- Breast Cancers.

Madeline Gough, Kayden K X Kwah, Tashbib Khan

|Aug 17, 2024
Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.

Jay Gunawardana, Soi C Law, Muhammed B Sabdia

|Aug 07, 2021
Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression.

Martina Proctor, Jazmina L Gonzalez Cruz, Sheena M Daignault-Mill

|Aug 05, 2021
ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression.

Helen Sheldon, Esther Bridges, Ildefonso Silva

Pageof 2